Article info
PDFPaper
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
- Correspondence to: Professor J P Zajicek Peninsula Medical School Room N16, ITTC Building, Tamar Science Park, Plymouth, Devon PL6 8BX, UK; john.zajicekphnt.swest.nhs.uk
Citation
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
Publication history
- Received April 25, 2005
- Accepted July 2, 2005
- Revised June 15, 2005
- First published November 16, 2005.
Online issue publication
November 16, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Journal of Neurology Neurosurgery and Psychiatry